IHSN Survey Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / PAK_2010_MICS-BAL_V01_M / variable [F1]
central

Multiple Indicator Cluster Survey 2010 - Balochistan

Pakistan, 2010
Get Microdata
Reference ID
PAK_2010_MICS-BAL_v01_M
Producer(s)
United Nations Children’s Fund, Planning and Development Department
Metadata
DDI/XML JSON
Created on
Mar 24, 2013
Last modified
Mar 29, 2019
Page views
59406
Downloads
10943
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Related Publications
  • Data files
  • ch
  • hh
  • hl
  • tn
  • wm

Days after fever started first took anti-malarial (ML11)

Data file: ch

Overview

Valid: 565
Invalid: 9867
Type: Discrete
Decimal: 0
Start: 202
End: 202
Width: 1
Range: -
Format:

Questions and instructions

Literal question
How long after the fever started did (name) first take (name of anti-malarial from ML6 or ML9)?
Categories
Value Category
0 Same day
1 Next day
2 2 days after the fever
3 3 days after the fever
4 4 or more days after the fever
8 DK
9 Missing
Sysmiss
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Interviewer instructions
This question asks about the time interval between the beginning of the child's fever and when he/she took the first dose of an anti-malarial medicine to treat the fever.

If multiple anti-malarial medicines are mentioned in ML6 or ML9, name all anti-malarials mentioned. Record the code for the day on which an anti-malarial was given for the first time. If he/she started taking (the anti-malarial) the same day the fever started, circle '0' for 'Same day'. If the anti-malarial was first given the next day (the day after the fever began), circle '1' for 'Next day' and so on. If the respondent does not know how long after the fever started the child first took the anti-malarial, circle '8'.
Back to Catalog
IHSN Survey Catalog

© IHSN Survey Catalog, All Rights Reserved.